HN2000000083A - Complejo farmaceutico - Google Patents

Complejo farmaceutico

Info

Publication number
HN2000000083A
HN2000000083A HN2000000083A HN2000000083A HN2000000083A HN 2000000083 A HN2000000083 A HN 2000000083A HN 2000000083 A HN2000000083 A HN 2000000083A HN 2000000083 A HN2000000083 A HN 2000000083A HN 2000000083 A HN2000000083 A HN 2000000083A
Authority
HN
Honduras
Prior art keywords
pharmaceutical complex
pharmaceutical
complex
invention refers
refers
Prior art date
Application number
HN2000000083A
Other languages
English (en)
Original Assignee
Inc Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc Pfizer filed Critical Inc Pfizer
Priority to HN2000000083A priority Critical patent/HN2000000083A/es
Publication of HN2000000083A publication Critical patent/HN2000000083A/es

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPLEJO FARMACEUTICO
HN2000000083A 2000-05-29 2000-05-29 Complejo farmaceutico HN2000000083A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2000000083A HN2000000083A (es) 2000-05-29 2000-05-29 Complejo farmaceutico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2000000083A HN2000000083A (es) 2000-05-29 2000-05-29 Complejo farmaceutico

Publications (1)

Publication Number Publication Date
HN2000000083A true HN2000000083A (es) 2001-04-20

Family

ID=53190359

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2000000083A HN2000000083A (es) 2000-05-29 2000-05-29 Complejo farmaceutico

Country Status (1)

Country Link
HN (1) HN2000000083A (es)

Similar Documents

Publication Publication Date Title
HN1999000066A (es) Formulaciones farmaceuticas
HN2001000139A (es) Interleuquina 2 estabilizada
HN1998000115A (es) Formas de dosificación farmacéuticas sólidas
HN1998000132A (es) Combinaciones terapeuticas
HN2001000072A (es) Contenedor
HN1999000125A (es) Nuevos derivados sustituidos del pirazol
HN1998000160A (es) Sistema constructivo modular hondulog
HN2000000083A (es) Complejo farmaceutico
HN2000000276A (es) Derivados de tiazolilamida
HN2000000188U (es) Arado combinado
HN2001000102A (es) Derivados de tropano utiles en terapia
HN2000000219A (es) Compuesto farmaceuticamente activos
HN2001200100A (es) Derivados de eteres de pirazol como agentes antinflamatorios analgesicos.
HN2000000242A (es) Derivados de higromicina
HN2001000135A (es) Derivados de purina
HN2000000062A (es) Compuestos de benzolactama sustituidos
HN1998000056A (es) Agente farmaceutico
HN1999000171A (es) Concentrado oral de sertralina.
HN2000000169A (es) Gen de srreptimyces avermiitilis que dirige la relacion de aavermectinas b2: b1
HN2000000205A (es) Derivados de purina
HN2000000247A (es) Quimioterapia de combinacion
HN1999000181A (es) Formulaciones antiparasitarias.
HN2000000015A (es) Sistema electronico dannilma
HN2000000064A (es) Compuestos quimicos
HN2002000014A (es) Copsan